Why is the sharing of data so crucial to #raredisease research? Tune in for today's full episode of Few & Far Between. Episode 10 features Sharon Terry, CEO at Genetic Alliance and #pseudoxanthomaelasticum (PXE) advocate.
Today on the Biorasi Few & Far Between podcast: What if you could read a story before its official release? Competitive intelligence gives you...
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...
"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can...